In silico identification of potential TALEN and CRISPR/Cas9 targets in Hepatitis B viral genome: A predictive approach for the treatment of viral infection.
JavaScript is disabled for your browser. Some features of this site may not work without it.
In silico identification of potential TALEN and CRISPR/Cas9 targets in Hepatitis B viral genome: A predictive approach for the treatment of viral infection.